AAA
MGNX icon

Affinity Asset Advisors’s MacroGenics MGNX Stock Holding History

Affinity Asset Advisors’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.45M Buy
500,000
+15,692
+3% +$33.5K 0.07% 97
2025
Q4 		$780K Buy
+484,308
New +$761K 0.04% 89
2021
Q3 		– Sell
-80,000
Closed -$2.15M – 85
2021
Q2 		$2.15M Buy
80,000
+55,000
+220% +$1.61M 0.77% 32
2021
Q1 		$796K Buy
+25,000
New +$607K 0.27% 53

Other funds holding MGNX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Affinity Asset Advisors's MGNX Position: Q1 2026 in Review

Affinity Asset Advisors increased its MacroGenics (MGNX) stake by 3.2% in Q1 2026, buying an estimated $33.5K and bringing the position to 500,000 shares worth $1.45M. The position accounts for 0.07% of the portfolio, ranked #97.

Affinity Asset Advisors first reported a position in MGNX in Q1 2021 and has held it in 4 quarters since. The position peaked at $2.15M in Q2 2021. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

  • Affinity Asset Advisors held 500,000 shares of MacroGenics worth $1.45M as of Q1 2026.
  • Affinity Asset Advisors bought 15,692 MacroGenics shares in Q1 2026, an estimated $33.5K.
  • MacroGenics made up 0.07% of Affinity Asset Advisors's portfolio in Q1 2026, its #97 holding.
  • Affinity Asset Advisors first reported a position in MacroGenics in Q1 2021 and has held it in 4 quarters since.
  • Affinity Asset Advisors's MacroGenics position peaked at $2.15M in Q2 2021.
  • 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Affinity Asset Advisors's 13F filing for Q1 2026, filed 14 May 2026.